8Oishi M, Mochizuki Y, Hara M, et al. Effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar infarction[J]. Clinic Neuropharmacol, 1996,19 (6) : 526 - 531.
9Nakazawa M, Lizuka K, Ujiie A, et al. Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase [J]. Yakugaku Zasshi,1994,114(12) :911 - 933.
二级参考文献5
1季祥武.内科疾病诊断标准（第一版）[M].青岛:青岛出版社,1991.196.
2季祥武，内科疾病诊断标准，1991年，196页
3陈清棠.临床神经病学[M].北京:中国科学技术出版社,2004:198-212.
4Fourcelot L,Trangquart F,Bray JM,et al.Uitrasound characterization and quantification of caroid atherosclerosis lesions[J].Minerva Cardioangiol,1999,47 (1):15 24.
4Jrgensen HS,Nakayama H,Raaschou HO,et al.Effect of blood pressure and diabetes on stroke in progression[J].Lancet,1994,344(8916):156-159.
5Bhalla A,Sankaralingam S,Tilling K,et al.Effect of acute glycaemic index on clinical outcome after acute stroke[J].Cerebrovasc Dis,2002,13(2):95-101.
6Arboix A,Rivas A,GarcíaEroles L,et al.Cerebral infarction in diabetes: clinical pattern,stroke subtypes,and predictors of inhospital mortality[J].BMC Neurol,2005,5(1):9.
7Amarenco P,Bogousslavsky J,Callahan A,et al.Highdose atorvastatin after stroke or transient ischemic attack[J].N Engl J Med,2006,355(6):549-559.
8Imamura T,Doi Y,Arima H,et al.LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study[J].Stroke,2009,40(2):382-388.
